Top Story

Patients achieve successful outcomes after Baerveldt implantation by residents

November 14, 2019

ELT Sight acquires excimer laser system assets from MLase

November 13, 2019
ELT Sight has acquired the IP and assets for MLase’s excimer ophthalmic laser system for glaucoma surgery, according to a press release. The company expects to…
In the Journals

Genetic variation for primary open-angle glaucoma found in those with African ancestry

November 11, 2019
Primary open-angle glaucoma may be associated with a genetic variation in individuals with African ancestry, a study found. The multicenter genome-wide association…
Meeting NewsVideo

VIDEO: Norlase unveils new Leaf laser

November 10, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Oliver Hvidt, CEO and co-founder of Norlase, discusses the company’s newest device, the…
More Headlines »

Medical Management of Glaucoma: A Closer Look at the Role of Nitric Oxide

This activity is supported by an educational grant from Bausch + Lomb.

Glaucoma is a leading cause of blindness worldwide, with an estimated 70 million people living with this condition…
More »
Meeting News

VIDEO: Switching to ab externo approach leads to better outcomes with Xen gel stent

June 3, 2019
More »
Meeting News

VIDEO: Bimatoprost SR shows continued IOP lowering at 1 year

October 18, 2019
More »